Develops and produces organic soil amendments. Creates living soils for high-value crops. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 26% below its peak. The market has trimmed its expectations for the company.
Our checks did not surface a specific strength to highlight here.
A loss of $3.1M against $0 in annual sales.
The stock sits at $0.74. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At last year’s rate of cash burn, the cash lasts less than a year. After that, the company needs to find new money.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
The takeaway: ARLSF is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.